These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23754970)

  • 1. Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers.
    Advokat C; Scheithauer M
    Front Neurosci; 2013; 7():82. PubMed ID: 23754970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD).
    Advokat C
    Neurosci Biobehav Rev; 2010 Jul; 34(8):1256-66. PubMed ID: 20381522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential for misuse and abuse of medications in ADHD: a review.
    Clemow DB; Walker DJ
    Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.
    Wilens TE; Adler LA; Adams J; Sgambati S; Rotrosen J; Sawtelle R; Utzinger L; Fusillo S
    J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):21-31. PubMed ID: 18174822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of pharmaceutical therapy of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults - health technology assessment.
    Benkert D; Krause KH; Wasem J; Aidelsburger P
    GMS Health Technol Assess; 2010 Sep; 6():Doc13. PubMed ID: 21289886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for adolescents and adults with ADHD: stimulant and nonstimulant medications and misuse of prescription stimulants.
    Weyandt LL; Oster DR; Marraccini ME; Gudmundsdottir BG; Munro BA; Zavras BM; Kuhar B
    Psychol Res Behav Manag; 2014; 7():223-49. PubMed ID: 25228824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review.
    Bagot KS; Kaminer Y
    Addiction; 2014 Apr; 109(4):547-57. PubMed ID: 24749160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulant medications for attention-deficit/hyperactivity disorder (ADHD) improve memory of emotional stimuli in ADHD-diagnosed college students.
    Maul J; Advokat C
    Pharmacol Biochem Behav; 2013 Apr; 105():58-62. PubMed ID: 23395972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress.
    Swanson J; Baler RD; Volkow ND
    Neuropsychopharmacology; 2011 Jan; 36(1):207-26. PubMed ID: 20881946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects.
    Lakhan SE; Kirchgessner A
    Brain Behav; 2012 Sep; 2(5):661-77. PubMed ID: 23139911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots.
    Poulin C
    Addiction; 2007 May; 102(5):740-51. PubMed ID: 17506151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.
    Martinez-Raga J; Knecht C; Szerman N; Martinez MI
    CNS Drugs; 2013 Jan; 27(1):15-30. PubMed ID: 23160939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Students' stimulant use for cognitive enhancement: A deliberate choice rather than an emotional response to a given situation.
    Ponnet K; Tholen R; De Bruyn S; Wouters E; Van Ouytsel J; Walrave M; Van Hal G
    Drug Alcohol Depend; 2021 Jan; 218():108410. PubMed ID: 33250387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmedical Use of Prescription Stimulants in Dental Hygiene Programs: Guidelines for prevention strategies.
    A'see KM; Cantey KB
    J Dent Hyg; 2019 Apr; 93(2):23-26. PubMed ID: 31015304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illicit Stimulant Use among Medical Students in Riyadh, Saudi Arabia.
    Alrakaf FA; Binyousef FH; Altammami AF; Alharbi AA; Shadid A; Alrahili N
    Cureus; 2020 Jan; 12(1):e6688. PubMed ID: 32104625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician perceptions of the use of medications for attention deficit hyperactivity disorder.
    Stockl KM; Hughes TE; Jarrar MA; Secnik K; Perwien AR
    J Manag Care Pharm; 2003; 9(5):416-23. PubMed ID: 14613439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder.
    Wigal SB; Wigal T; Schuck S; Brams M; Williamson D; Armstrong RB; Starr HL
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):121-31. PubMed ID: 21488750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use.
    Arria AM; Caldeira KM; O'Grady KE; Vincent KB; Johnson EP; Wish ED
    Pharmacotherapy; 2008 Feb; 28(2):156-69. PubMed ID: 18225963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats.
    Garland EJ
    J Psychopharmacol; 1998; 12(4):385-95. PubMed ID: 10065914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.